Resources

Lights, Camera, Bankrupt. Our FRISK® score broadcasted the financial dangers hidden within Minnesota-based media company iMedia Brands, Inc., a debt-laden enterprise hurt by declining cable TV subscribers and inflation.

Powering down: IT infrastructure leader Cyxtera Technologies filed for bankruptcy protection in the wake of major losses and on the eve of fast-arriving debt maturities.

Struggling with debt and declining sales, ATM and Point of Sale tech manufacturer Diebold Nixdorf, Inc. has filed for Chapter 11 protection. Our subscribers, armed with the FRISK® Score, would have made an early withdrawal before bankruptcy struck.

Bankruptcy has claimed British chemical manufacturer Venator Materials PLC after years of struggle with both high European energy costs and waning demand.

Continuing deterioration in operating performance and intense pricing pressure from competitors were tough pills to swallow for generic pharmaceutical manufacturer Lannett Company, Inc., ultimately leading to its bankruptcy.

Cash-strapped home goods retailer Bed Bath & Beyond is now bankrupt, capping one of the craziest documented descents into Chapter 11 seen by our clients in some time.

Highly leveraged Lucira Health, Inc., maker of at-home COVID-19 and flu tests, went bankrupt after pandemic restrictions universally eased and demand for company wares subsequently plummeted.

Bankruptcy has come for Tuesday Morning Corporation, the once-popular off-price retailer that buckled after lenders put the kibosh on the company’s ability to borrow additional money to finance operations.

For the second time in six years, Avaya Holdings Corporation is filing for bankruptcy protection. The multinational tech firm struggled to hit earnings targets in 2022 as it continues to fully convert its business model to the cloud.

The party's over. Party City Holdco put up a fight, but suffocating debt and supply chain woes forced the American retailer into Chapter 11 bankruptcy.

Clovis Oncology, Inc. has filed for bankruptcy due to the combination of poor sales tied to its cancer drug, Rubraca, and a significant debt load.

The end credits have rolled for Cineworld Group plc, a global movie theater icon toppled by high leverage, debt, and a changing post-pandemic consumer environment.